These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1680 related articles for article (PubMed ID: 28241817)

  • 1. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
    Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
    FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.
    Yan HM; Xia MF; Wang Y; Chang XX; Yao XZ; Rao SX; Zeng MS; Tu YF; Feng R; Jia WP; Liu J; Deng W; Jiang JD; Gao X
    PLoS One; 2015; 10(8):e0134172. PubMed ID: 26252777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD.
    Yang S; Cao SJ; Li CY; Zhang Q; Zhang BL; Qiu F; Kang N
    J Ethnopharmacol; 2024 Oct; 332():118354. PubMed ID: 38762210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats.
    Ma Z; Chu L; Liu H; Wang W; Li J; Yao W; Yi J; Gao Y
    Sci Rep; 2017 Mar; 7():44819. PubMed ID: 28300221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
    Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
    Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
    Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
    J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease.
    Park H; Liu Y; Kim HS; Shin JH
    Nutr Res; 2016 Jan; 36(1):57-64. PubMed ID: 26773781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway.
    Wu H; Jin M; Han D; Zhou M; Mei X; Guan Y; Liu C
    Biochem Biophys Res Commun; 2015 Mar; 458(4):862-8. PubMed ID: 25701781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
    Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
    Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway.
    Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH
    Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
    Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress.
    Zhang Z; Li B; Meng X; Yao S; Jin L; Yang J; Wang J; Zhang H; Zhang Z; Cai D; Zhang Y; Ning G
    Sci Rep; 2016 Feb; 6():20848. PubMed ID: 26857750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
    Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
    Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats.
    Gu JJ; Gao FY; Zhao TY
    J Physiol Pharmacol; 2012 Oct; 63(5):505-13. PubMed ID: 23211304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.